{"schema_version":"secwatch.filing_event.v1","accession":"0000096943-22-000102","form_type":"8-K","ticker":"TFX","cik":"0000096943","company_name":"TELEFLEX INC","filed_at":"2022-10-27T23:59:59+00:00","discovered_at":"2026-05-14T18:03:54.139070+00:00","generated_at":"2026-06-23T00:38:13.833148+00:00","sec_items":["2.02","7.01","9.01"],"event_type":"earnings","sentiment":"negative","materiality_score":0.7,"calibrated_materiality_score":0.7,"confidence":"high","headline":"Teleflex Q3 revenue down 1.9% YoY; cuts FY 2022 GAAP & adjusted EPS guidance","bullets":["Q3 revenue $686.8M (-1.9% reported; +2.4% constant currency); GAAP EPS $2.16 vs $4.20 prior.","Adjusted diluted EPS $3.27, down from $3.51; full-year adjusted EPS guidance lowered to $12.80-$13.20 from $13.00-$13.40.","GAAP revenue growth guidance lowered to (0.75)% to 0.25%; constant currency growth maintained at 3.25%-4.25%.","Acquired Standard Bariatrics during Q3; expects revenue and margin accretion over time.","Americas revenue -2.9% reported, Asia +9.4%; supply chain challenges persist but logistics stabilizing."],"urls":{"canonical":"https://secwatch.observer/filing/0000096943-22-000102","json":"https://secwatch.observer/filing/0000096943-22-000102.json","markdown":"https://secwatch.observer/filing/0000096943-22-000102.md","text":"https://secwatch.observer/filing/0000096943-22-000102.txt","edgar_index":"https://www.sec.gov/Archives/edgar/data/96943/000009694322000102/0000096943-22-000102-index.htm","edgar_primary_document":"https://www.sec.gov/Archives/edgar/data/96943/000009694322000102/tfx-20221027.htm"},"model":{"generated_by":"deepseek-v4-flash:cloud@v2","generated_at":"2026-06-23T00:38:13.833148+00:00"},"review":{"review_status":"machine_generated","human_reviewed":false,"corrected":false,"correction_note":null,"correction_timestamp":null,"superseded_by":null,"related_filings":[]},"source_grounded_claims":[],"license":"Source filings: public domain (SEC EDGAR). Summaries (headline + bullets): CC-BY-4.0; attribute https://secwatch.observer"}